Analysis of curative effect of implantation of radioactive seeds on inoperable early-stage non-small cell lung cancer
10.3969/j.issn.1000-8179.20140487
- VernacularTitle:放射性粒子植入治疗不能手术的早期非小细胞肺癌疗效分析
- Author:
Jingkui YANG
;
Jinshuang LV
;
Weiliang YAN
;
Guangjun ZHENG
;
Zhen FENG
;
Xiaodong HUO
- Publication Type:Journal Article
- Keywords:
inoperable;
non-small cell lung cancer;
125I radioactive seeds;
curative effect
- From:
Chinese Journal of Clinical Oncology
2014;(17):1111-1114
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the curative effect of computed tomography (CT)-guided percutaneous implantation of 125I radioactive seeds on inoperable early-stage non-small cell lung cancer (NSCLC). Methods:From January 2003 to December 2012, we selected 48 patients who had pathologically confirmed early-stage NSCLC (stageⅠ, 18 cases;stageⅡ, 30 cases with N0). We treated the nidus by CT-guided percutaneous implantation of 125I radioactive seeds. Six months after implantation, the chest CT-scan was reviewed, and the effect of the treatment was evaluated according to the international standards. Final follow-up was performed in December 2013. Results:All operations were successfully completed. The target tumor matched peripheral doses (MPDs) were 215.8±14.3 Gy (D100), 106.8±11.6 Gy (D90), and 148.6± 17.3 Gy (D90>MPD). Six months after implantation, chest CT was reviewed, and treatment effects were evaluated. The percentages of stage I patients achieving complete relief (CR), partial relief (PR), stable disease (SD), and progressive disease (PD) were 27.8%(5 cases), 72.2%(13 cases), 0%, and 0%, respectively. Among stageⅡpatients, CR, PR, SD, and PD percentages were 0%(3 cases), 73.3%(22 cases), 13.3%(4 cases), and 3.3%(1 case), respectively. The effective rate was 89.6%. The 1-year local control rate was 85%. Until December 2013, the 1-, 2-, and 5-year cumulative survival rates up to the end of the interval were 95.8%(46/48), 81.3%(39/48), and 56.3%(27/48), respectively. Conclusion:CT-guided percutaneous implantation of 125I radioactive seeds is an effective micro-invasive method for treating inoperable early-stage NSCLC.
